Ot Broadcast News
The Disappointment of the NSABP C-08 Trial
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:09:05
- Mais informações
Informações:
Sinopse
Norman Wolmark on the study's frustrating but unequivocal results showing that bevacizumab did not extend disease-free survival in adjuvant therapy for early colon cancer at 3 years, even though there had been a benefit at 1 year. Also weighing in: Nicholas Petrelli
